99mTc-aminohexylidendiphosphonate and 99mTc-pyrophosphate in the scintigraphic diagnosis of experimental cardiomyopathy in dogs

Nuklearmedizin. 1987 Oct;26(5):220-3.

Abstract

Experimental cardiomyopathy was provoked in 24 dogs with high intravenous doses of adrenaline and theophylline. These lesions were studied by means of the new agent 99mTc-AHDP and 99mTc-PYP in comparison. Cardiomyopathy could be imaged as early as 4 h after the onset of involvement but not later than 7 days. A maximum accumulation occurred in lesions 24 h old. 99mTc uptake in the myocardium was graded scintigraphically. 99mTc-AHDP was accumulated in the altered myocardium to a greater extent than 99mTc-PYP. Scintigraphic findings were in good agreement with plasma levels of creatine-kinase. A comparison with histology demonstrated that the maximum accumulation of radiopharmaceuticals occurred at the time when the development of myocardium involvement reached the stage of myocytolysis.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Cardiomyopathies / chemically induced
  • Cardiomyopathies / diagnostic imaging*
  • Diphosphates*
  • Diphosphonates*
  • Dogs
  • Epinephrine
  • Organometallic Compounds*
  • Organophosphorus Compounds*
  • Organotechnetium Compounds*
  • Radionuclide Imaging
  • Technetium Tc 99m Pyrophosphate
  • Technetium*
  • Theophylline

Substances

  • Diphosphates
  • Diphosphonates
  • Organometallic Compounds
  • Organophosphorus Compounds
  • Organotechnetium Compounds
  • technetium Tc 99m aminohexylidendiphosphonate
  • Technetium Tc 99m Pyrophosphate
  • Technetium
  • Theophylline
  • Epinephrine